Photo of Darrell WuDunn, M.D., Ph.D.

Darrell WuDunn, M.D., Ph.D.

Professor and Chair, Department of Ophthalmology

Darrell WuDunn, M.D., Ph.D., is a professor and chair of ophthalmology the University of Florida College of Medicine – Jacksonville.

WuDunn has more than 20 years of glaucoma-focused clinical experience. He previously held appointments in Indianapolis at IU Health University Hospital, Riley Hospital for Children, Eskenazi Health and the Richard L. Roudebush Veterans Affairs Medical Center. He also saw patients at Eugene and Marilyn Glick Eye Institute.

At Indiana University, WuDunn oversaw a residency program that grown significantly over the past decade. With 18 residents a year, it stands as one of the largest ophthalmology residency programs in the country. During his tenure there, WuDunn trained more than 130 residents and 20 fellows in the care of glaucoma and related diseases.

WuDunn earned his medical degree from the University of Chicago Pritzker School of Medicine and a PhD in molecular and cellular virology, also from the University of Chicago. He completed his residency in ophthalmology at the University of Southern California, Los Angeles County Medical Center and the Doheny Eye Institute. He then completed a fellowship in glaucoma at the University of Miami and Bascom Palmer Eye Institute in South Florida.

His research covers both the clinical and basic science of ophthalmology, especially relating to glaucoma, with a recent move toward translational research. He has extensive experience in industry-sponsored clinical trials and has had dozens of journal articles published on glaucoma surgery outcomes.

WuDunn is a member of the American Academy of Ophthalmology, for which he served eight years as the glaucoma section editor of its multifaceted Ophthalmic News and Education Network. He also serves on the Scientific Grants Review Committee for the BrightFocus Foundation, a nonprofit organization that supports research and provides public education on brain and eye diseases. It’s one of the largest funding programs devoted to glaucoma research.